Cargando…
Cell Cycle Model System for Advancing Cancer Biomarker Research
Progress in understanding the complexity of a devastating disease such as cancer has underscored the need for developing comprehensive panels of molecular markers for early disease detection and precision medicine applications. The present study was conducted to assess whether a cohesive biological...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740075/ https://www.ncbi.nlm.nih.gov/pubmed/29269772 http://dx.doi.org/10.1038/s41598-017-17845-6 |
_version_ | 1783287974743506944 |
---|---|
author | Lazar, Iulia M. Hoeschele, Ina de Morais, Juliana Tenga, Milagros J. |
author_facet | Lazar, Iulia M. Hoeschele, Ina de Morais, Juliana Tenga, Milagros J. |
author_sort | Lazar, Iulia M. |
collection | PubMed |
description | Progress in understanding the complexity of a devastating disease such as cancer has underscored the need for developing comprehensive panels of molecular markers for early disease detection and precision medicine applications. The present study was conducted to assess whether a cohesive biological context can be assigned to protein markers derived from public data mining, and whether mass spectrometry can be utilized to screen for the co-expression of functionally related biomarkers to be recommended for further exploration in clinical context. Cell cycle arrest/release experiments of MCF7/SKBR3 breast cancer and MCF10 non-tumorigenic cells were used as a surrogate to support the production of proteins relevant to aberrant cell proliferation. Information downloaded from the scientific public domain was queried with bioinformatics tools to generate an initial list of 1038 cancer-associated proteins. Mass spectrometric analysis of cell extracts identified 352 proteins that could be matched to the public list. Differential expression, enrichment, and protein-protein interaction analysis of the proteomic data revealed several functionally-related clusters of relevance to cancer. The results demonstrate that public data derived from independent experiments can be used to inform biological research and support the development of molecular assays for probing the characteristics of a disease. |
format | Online Article Text |
id | pubmed-5740075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-57400752018-01-03 Cell Cycle Model System for Advancing Cancer Biomarker Research Lazar, Iulia M. Hoeschele, Ina de Morais, Juliana Tenga, Milagros J. Sci Rep Article Progress in understanding the complexity of a devastating disease such as cancer has underscored the need for developing comprehensive panels of molecular markers for early disease detection and precision medicine applications. The present study was conducted to assess whether a cohesive biological context can be assigned to protein markers derived from public data mining, and whether mass spectrometry can be utilized to screen for the co-expression of functionally related biomarkers to be recommended for further exploration in clinical context. Cell cycle arrest/release experiments of MCF7/SKBR3 breast cancer and MCF10 non-tumorigenic cells were used as a surrogate to support the production of proteins relevant to aberrant cell proliferation. Information downloaded from the scientific public domain was queried with bioinformatics tools to generate an initial list of 1038 cancer-associated proteins. Mass spectrometric analysis of cell extracts identified 352 proteins that could be matched to the public list. Differential expression, enrichment, and protein-protein interaction analysis of the proteomic data revealed several functionally-related clusters of relevance to cancer. The results demonstrate that public data derived from independent experiments can be used to inform biological research and support the development of molecular assays for probing the characteristics of a disease. Nature Publishing Group UK 2017-12-21 /pmc/articles/PMC5740075/ /pubmed/29269772 http://dx.doi.org/10.1038/s41598-017-17845-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Lazar, Iulia M. Hoeschele, Ina de Morais, Juliana Tenga, Milagros J. Cell Cycle Model System for Advancing Cancer Biomarker Research |
title | Cell Cycle Model System for Advancing Cancer Biomarker Research |
title_full | Cell Cycle Model System for Advancing Cancer Biomarker Research |
title_fullStr | Cell Cycle Model System for Advancing Cancer Biomarker Research |
title_full_unstemmed | Cell Cycle Model System for Advancing Cancer Biomarker Research |
title_short | Cell Cycle Model System for Advancing Cancer Biomarker Research |
title_sort | cell cycle model system for advancing cancer biomarker research |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740075/ https://www.ncbi.nlm.nih.gov/pubmed/29269772 http://dx.doi.org/10.1038/s41598-017-17845-6 |
work_keys_str_mv | AT lazariuliam cellcyclemodelsystemforadvancingcancerbiomarkerresearch AT hoescheleina cellcyclemodelsystemforadvancingcancerbiomarkerresearch AT demoraisjuliana cellcyclemodelsystemforadvancingcancerbiomarkerresearch AT tengamilagrosj cellcyclemodelsystemforadvancingcancerbiomarkerresearch |